What are SGLT2 Inhibitors?

What are SGLT2 Inhibitors? New research uncovers the potential benefits and risks of sodium-glucose cotransporter 2 (SGLT2) inhibitors for adults aged 80 years or older with chronic kidney disease (CKD). SGLT2 (Sodium-Glucose Cotransporter-2) inhibitors are a class of medications primarily used to treat Type 2 diabetes (T2D).
T2D, the most common type of diabetes, is
Read the full report on Crackittoday
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Crackittoday
- Reporter
- kumari sonali
- Published
- Wednesday, 28 October 2026, 9:28 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Crackittoday with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

